Overview
Masahiro Sekiguchi practices in Tokyo, Japan. Mr. Sekiguchi is rated as an Advanced expert by MediFind in the treatment of Hepatoblastoma. His top areas of expertise are Hepatoblastoma, Testicular Yolk Sac Tumor, Pancreatoblastoma, and Rhabdoid Tumor.
His clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Hepatoblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- HepatoblastomaMr. Sekiguchi isAdvanced. Learn about Hepatoblastoma.
- Testicular Yolk Sac TumorMr. Sekiguchi isAdvanced. Learn about Testicular Yolk Sac Tumor.
- Experienced
- Aase SyndromeMr. Sekiguchi isExperienced. Learn about Aase Syndrome.
- Acute Lymphoblastic Leukemia (ALL)Mr. Sekiguchi isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaMr. Sekiguchi isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- AnemiaMr. Sekiguchi isExperienced. Learn about Anemia.
- Aplastic AnemiaMr. Sekiguchi isExperienced. Learn about Aplastic Anemia.
- Clear Cell SarcomaMr. Sekiguchi isExperienced. Learn about Clear Cell Sarcoma.